Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea

NCT06317064 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Dysmenorrhea

Interventions

DRUG: Ibuprofen and Aprepitant

Sponsor

Lahore Medical Research Center, LLP